| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . |
# |
Score |
Template |
Links and tools | %id | First |
MWESKFVKEGLTFDDVLLVPAKSDVLPREVSVKTVLSESLQLNIPLISAGMDTVTEADMAIAMARQGGLGIIHKNMSIEQQAEQVDKVKRSESGVISDPFFLTPEHQVYDAEHLMGKYRISGVPVVNNLDERKLVGIITNRDMRFIQDYSIKISDVMTKEQLITAPVGTTLSEAEKILQKYKIEKLPLVDNNGVLQGLITIKDIEKVIEFPNSAKDKQGRLLVGAAVGVTADAMTRIDALVKASVDAIVLDTAHGHSQGVIDKVKEVRAKYPSLNIIAGNVATAEATKALIEAGANVVKVGIGPGSICTTRVVAGVGVPQLTAVYDCATEARKHGIPVIADGGIKYSGDMVKALAAGAHVVMLGSMFAGVAESPGETEIYQGRQFKVYRGMGSVGAMEKGSKDRYFQEGNKKLVPEGIEGRVPYKGPLADTVHQLVGGLRAGMGYCGAQDLEFLRENAQFIRMSGAGLLESHPHHVQITKEAPNYSL | Last |
1 | -117.000 | [F] KOG2550 IMP dehydrogenase/GMP reductase |
ali follow.. |
41 | 27 | .......ADDLTYNDFLILPGFIDFIADEVDLTSALTRKITLKTPLISSPMDTVTEADMAIAMALMGGIGFIHHNCTPEFQANEVRKVKNFEQGFITDPVVLSPSHTVGDVLEAKMRHGFSGIPITETGTGSKLVGIVTSRDIDFLAEKDLLSEVMTPRIELVVAPAGVTLKEANEILQRSKKGKLPIVNDCDELVAIIARTDLKKNRDYPLASKDSQKQLLCGAAVGTREDDKYRLDLLTQAGVDVIVFHSSQGNSVYQIAMVHYIKQKYPHLQVIGGNVVTAAQAKNLIDAGVDGLRVGMGCGSICITQEVMACGRPQGTAVYKVAEYARRFGVPIIADGGIQTVGHVVKALALGASTVMMGSLLAATTEAPGEYFFSDGVRLKKYRGMGSLDPMEKSSSSQYFSEGDKVKIAQGVSGSIQDKGSIQKFVPYLIAGIQHGCQDIGARSLSVLRSELKFEKRTMSPQIEGGVHGLHSYEKR..... |
512 |
2 | -91.400 | [F] COG0516 IMP dehydrogenase/GMP reductase |
ali follow.. |
71 | 1 | .............................................................................................................................................................................................................KVIEFPNSAKDKHGRLLAAAAVGITNDTFVRVEKLIEAGVDAIVIDTAHGHSAGVINKISEIRQTFKDVVIVAGNVATAEGARALFEVGVDIVKVGIGPGSICTTRVVAGVGVPQITAIYDCATVAREFGKTIIADGGIKYSGDIVKALAAGGNAVMLGSMLAGTDESPGETEIFQGRQFKTYRGMGSLAAMEHGSKDRYFQADAKKLVPEGIEGRVPYKGSVADIIFQLVGGIRSGMGYTGSPDLRHLREEAAFVRMTGAGLRESHPHDIQITKEAPNYSI |
282 |
3 | -15.500 | [G] COG3010 Putative N-acetylmannosamine-6-phosphate epimerase |
ali follow.. |
16 | 87 | ........................................................................................................................................................................................................................................FLQDIEELAAAGADIIAFDGTDRVRPTTREAI--IKRIKELGCLAMADCSNFEEGMYCHNLGVEII----------STMSGYTGGEIPAEPDYQLVKDLNAAGCRVMAEGRYNTPELAKTAIEIGAYSVTVGSALTRLEH................................................................................................................... |
215 |
4 | -14.600 | [R] COG2070 Dioxygenases related to 2-nitropropane dioxygenase |
ali follow.. |
10 | 4 | ...............................IFDPLVIRGKSLTPIVQGGMGVVSASGLSSAVARENGIGTI--DLRHLHEDLLAESQINPSEEKYTSLNCTALDREIQKAKSASEGKGLIAVNVMK-----------------------------------------------------------------------------------------------------AVKDHAAYVRQACESGADAVVMGAGLPLDLPEMTEGYHKD-------ALLPILSESRGINIVLILPDAIVHAA-GHLGASTVEGVNDAKFDFKRVIEETFEVLESEKIPLILAGGMANFEKVKTALNWGASAVQIGTAFAVTEEGDAHLNFKKGLPARGVRSKFLDSDIQLAAAFRGEVDKGLFFRGKDPLPFGNAIRTVRETIQYLLTGSEPVAT........................................... |
388 |
5 | -13.700 | [C] COG1304 L-lactate dehydrogenase (FMN-dependent) and related alpha-hydroxy acid dehydrogenases |
ali follow.. |
15 | 41 | ...........DLENIALRQRVLK-DMSELDTSIELFGE-KLSMPTILAPVGA-GEVQAAQAADNKGVPFTLSTVSICP-----IEEVAPAIKRPMWFQLYVLKDRGFMKNALERAKAAGCSTLVFTVDMP-------------------------------TPGARYRDMHSGMSGPYKEIRRVLQGFTHPFWAYDVGIKGKPHTLGNVSTYMGRQIGLDDYIGWLTENFDPSIS-------------------------KDLEWIREFWEGPMVIKG-ILDPEDAKDAVRFGADGIVVSNHGG-----RQLDGV-LSSARALPPIADAVKG-DIKIIADSGIRNGLDIVRMLALGADATMLGRAFVYALGAEGR---------------------------------------QG----------VENMLDIFKKEMHVAMTLTSNRTIADIKPE.............................. |
373 |
6 | -12.900 | [C] KOG0538 Glycolate oxidase |
ali follow.. |
26 | 214 | .....................................................................................................................................................................................................................................................................KDIKWLQSIT-SLPILVKGVITAEDARIAVEYGAAGIIVSNHGA-----RQLDYV-PATIVALEEVVKAVEG-RIPVFLDGGVRRGTDVFKALALGASGVFVGRPSLFSLAADGE---------------------------------------AG----------VRKMLQMLRDEFELTMALSGCRSLREISRT.............................. |
352 |
7 | -11.600 | [K] COG4109 Predicted transcriptional regulator containing CBS domains |
ali follow.. |
15 | 158 | ..........................................ELPILSTSYDTFTVATMINRAIYDQ---IKKEVVFVEDILTPLETT-----------AYLSTSDKVEDWHKMEEATGHSRFPVV--NRAMRLTGMVTSKDILEKNPSISIERVMT--KNPLTVGPKMSVASVAHMMIWESIEVIPVVKDDLTLIGIVSRQDILKSMQMIQKQPQVGETIDDTIAKADTGEEADYEFKVSPQMTNSLGTLSYGVFTQVVCEVVQQKLFSMKKRNVAIENVTMYFQMDATIVIKPRILEMGRKAGKLDVELYLEGILTGKAIVACQMME.............................................................................................................................................................. |
436 |
8 | -11.500 | [H] COG2022 Uncharacterized enzyme of thiazole biosynthesis |
ali follow.. |
21 | 158 | ..........................................................................................................................................................................................................................................................................................DPVLCKRLEEVGCAAVMP---------APIGSNQGLETRAMLEIIIQQAT---VPVVVDAGIGVPSHAAQALEMGADAVLVNTAIAVADD-------------PVNMAKAFRLAVEAGLLAPQSGPGSRSYFAHATS---PLTGFLEASV....................................................... |
281 |
9 | -11.300 | [K] COG1954 Glycerol-3-phosphate responsive antiterminator (mRNA-binding) |
ali follow.. |
15 | 1 | ......................................................................................................................................................................................MPXLHLLRQNPVIAAVKDNASLQLAIDSECQF--------ISVLYGNICTISQIVKKIKNAGKYAFIVDLLEGASNKE-VVIQFLKLVTEADGIISTKASMLKAAR---AEGFFCIHRLFIVDSISFHNIDKQVAQSNPDCI--LGWVTEKIRQPLIAGGLVCDEEDARNAINAGVVALSTTN.......................................................................................................................... |
180 |
10 | -10.300 | [I] COG4981 Enoyl reductase domain of yeast-type FAS1 |
ali follow.. |
11 | 28 | .........................VDGTPRLVTKFTELTGRT-PMMLAGMPTTVDPAIVAAAANGGHWAEL--QVTPELLETHIAQLTDMLEPGINAQFNSMFLDPYLWKMQI----------------------------------------------------------GGKRLVPKARANGASIDG------------------------------IVITAGIPEKDEAVALVKELMRDGFPWIAFKPG-----------------------AIKQVNSVLAIAKEVPELPIIIQIGGVAGG-------HSWEDLDELLIATYGKVRALDNVVLCVGGGIGSPERAADYVAMPVDGILVGTAAMATKEATTSQAVKE.......................................................................................................... |
280 |
11 | -10.100 | [R] COG0517 FOG: CBS domain |
ali follow.. |
23 | 7 | ..............................................................................................MTRKVVYISPDITVSHAADLMREQGLHRLPVIEND---QLVGLVTEGTIAQASPSKATSLSIVMIRDVVTVSGYASLEDATYLMLKNKISILPVVDN-HQVYGVITDRDVFQA........................................................................................................................................................................................................................................................................................ |
129 |
12 | -9.880 | [R] COG1646 Predicted phosphate-binding enzymes, TIM-barrel fold |
ali follow.. |
17 | 22 | ............................................................................................................................................................................................................................TLIDPEEQTPEEAVEIARAAIRGGTDGIMLGGSTTDSSELDNTARALRENID--------IILFPGNTTGVSRYADAIFF-VEPGGMRLFYLEAGSGAPEHVPEEMIALVKRCTDQILIVGGGIRSGEDAARVAGAGADVVVTGTVVENSDNVEDKI.............................................................................................................. |
238 |
13 | -9.500 | [E] COG0106 Phosphoribosylformimino-5-aminoimidazole carboxamide ribonucleotide (ProFAR) isomerase |
ali follow.. |
18 | 29 | .....................................................................................................................................................................................................................................NPDPAAQARAFEEQGFEVVDLNGAFAGETVNGAAVDAILKATKNPVQLGGGIRTLEHIENWLSRGLKRVILGAGVAAIIYTDIDRD-GILTGINWASTLELADAVSIPVIASGGLASMDDIRRMTEPKLEGAISGRAL........................................................................................................................ |
225 |
14 | -9.440 | [G] COG0269 3-hexulose-6-phosphate synthase and related proteins |
ali follow.. |
15 | 1 | ............................................................................................................................................................MSLPMLQVALDNQTMDSAYETTRL--------IAEEVDIIEVGTILCVGEGVRAVRDLKALYPHKIVLADAKIADAGKILSRMCFEANADWVTV-ICCADINTAKGALDVAKEFNGDVQIELTGYWTWEQAQQWRDAGIGQVVYHRSRDA----------GVAWGEADITAIKRLSDMGFKVTVTGGLA-LEDLPLFKGIPIHVFIAGRSIRDAAS-PVEAARQFKRSIAELWG................................................................................................. |
216 |
15 | -9.430 | [G] COG0800 2-keto-3-deoxy-6-phosphogluconate aldolase |
ali follow.. |
18 | 13 | ........................................................................................................................................................................................................................TTGPVVPVIVVNKLEHAVPMAKALVAGGVRVLEVTL---RTACAMDAIRAIAKEVPEAIVGAGTVLNPQQLAEVTEAGAQFATIPLIPGISTVSELMLGMGTKALQAIAGPFS-----QVRFCPTGGI-SPANYRDYLALKSVLCIGGSWLVPAD.................................................................................................................... |
190 |
16 | -9.170 | [E] COG0107 Imidazoleglycerol-phosphate synthase |
ali follow.. |
20 | 31 | ......................................................................................................................................................................................................................................GDPVEIARRYDEQGADEITITASVDGRDTTLHTVERMASQVFIPLTVGGGVRSVQDIRNLLNAGADKVSINLGAGEILLTSMDQD-GVKSGYDLGVTRAISEAVNVPVIASGGVGNLEHLAAGILEGADAVLAASIF........................................................................................................................ |
234 |